535 MADISON AVENUE, 20TH FLOOR, NEW YORK, NY
Financial Results, Reg. FD
Shareholder votes
News, Securities Holder Rights or Indentures
News, Material Contracts
Q3
Q2
FY 2023
Q1
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Confidential Treatment Order
Post-Effective Amendment to Registration Statement
S-11